open access
Depression and quality of life among cancer patients undergoing chemotherapy
, 2, 1
Affiliations- Universitas Muhammadiyah Yogyakarta, Jl Brawijaya Tamantirto Kasihan, 55182 Bantul, Indonesia
- Universitas Qamarul Huda, Indonesia
open access
Abstract
Background. Cancer is a leading cause of death globally and in Indonesia. Cancer itself and the treatment often cause physical and psychological changes that affect patients’ quality of life (QoL). This study aimed to determine the level of depression and QoL in cancer patients.
Material and methods. This cross-sectional study involved 94 respondents who had chemotherapy in a public hospital in Indonesia. The study was conducted from January to April 2018. The depression level was assessed using the Beck Depression Inventory II (BDI II) while patients’ QoL was measured using the EORTC QLQ-C30. Data were analysis using Pearson correlation.
Results. The present study found that the mean score of depression was 8.65 ± 6.53, which reflected their normal condition. The global QoL for patients with cancer in this study was high. The levels of depression and QoL in the study were contrary to previous studies. Fatigue and pain were the top two highest scores in the symptom scales. The study indicates moderate negative correlation between global QoL and depression. There is a need to develop intervention and management of patients undergoing chemotherapy to maintain patients’ QoL and psychological aspects of care.
Palliat Med Pract 2020; 4, 1: 1–6
Abstract
Background. Cancer is a leading cause of death globally and in Indonesia. Cancer itself and the treatment often cause physical and psychological changes that affect patients’ quality of life (QoL). This study aimed to determine the level of depression and QoL in cancer patients.
Material and methods. This cross-sectional study involved 94 respondents who had chemotherapy in a public hospital in Indonesia. The study was conducted from January to April 2018. The depression level was assessed using the Beck Depression Inventory II (BDI II) while patients’ QoL was measured using the EORTC QLQ-C30. Data were analysis using Pearson correlation.
Results. The present study found that the mean score of depression was 8.65 ± 6.53, which reflected their normal condition. The global QoL for patients with cancer in this study was high. The levels of depression and QoL in the study were contrary to previous studies. Fatigue and pain were the top two highest scores in the symptom scales. The study indicates moderate negative correlation between global QoL and depression. There is a need to develop intervention and management of patients undergoing chemotherapy to maintain patients’ QoL and psychological aspects of care.
Palliat Med Pract 2020; 4, 1: 1–6
Keywords
cancer, chemotherapy, depression, Indonesia, quality of life
About this articleTitle
Depression and quality of life among cancer patients undergoing chemotherapy
Journal
Palliative Medicine in Practice
Issue
Article type
Research paper
Pages
1-6
Published online
2020-05-08
Page views
1303
Article views/downloads
949
DOI
Bibliographic record
Palliat Med Pract 2020;14(1):1-6.
Keywords
cancer
chemotherapy
depression
Indonesia
quality of life
Authors
Erna Rochmawati
Erwin Wiksuarini
Rahmah Rahmah
References (28)- World Health Organization. Cancer, 2018.
- IARC. Globocan 2008: country fast stat: International Agency on Research Cancer; 2008 [updated 2008]. http://globocan.iarc.fr/factsheet.asp.
- Soebadi RD, Tejawinata S. Indonesia: status of cancer pain and palliative care. J Pain Symptom Manage. 1996; 12(2): 112–115.
- Fles R, Wildeman MA, Sulistiono B, et al. Knowledge of general practitioners about nasopharyngeal cancer at the Puskesmas in Yogyakarta, Indonesia. BMC Med Educ. 2010; 10: 81.
- van den Beuken-van Everdingen MHJ, de Rijke JM, Kessels AG, et al. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol. 2007; 18(9): 1437–1449.
- Yamagishi A, Morita T, Miyashita M, et al. Pain intensity, quality of life, quality of palliative care, and satisfaction in outpatients with metastatic or recurrent cancer: a Japanese, nationwide, region-based, multicenter survey. J Pain Symptom Manage. 2012; 43(3): 503–514.
- Abu-Saad Huijer H, Abboud S, Doumit M, et al. Health-related quality of life among breast cancer patients in Lebanon. Eur J Oncol Nurs. 2012; 16(5): 491–497.
- Halawi R, Aldin ES, Baydoun A, et al. Physical symptom profile for adult cancer inpatients at a Lebanese cancer unit. Eur J Intern Med. 2012; 23(8): e185–e189.
- Teunissen SC, Wesker W, Kruitwagen C, et al. Symptom prevalence in patients with incurable cancer: a systematic review. J Pain Symptom Manage. 2007; 34(1): 94–104.
- Nayak MG, George A, Vidyasagar MS, et al. Quality of Life among Cancer Patients. Indian J Palliat Care. 2017; 23(4): 445–450.
- Huang X, Naghdy F, Naghdy G, et al. The Combined Effects of Adaptive Control and Virtual Reality on Robot-Assisted Fine Hand Motion Rehabilitation in Chronic Stroke Patients: A Case Study. J Stroke Cerebrovasc Dis. 2018; 27(1): 221–228.
- Wilson KG, Chochinov HM, Skirko MG, et al. Depression and anxiety disorders in palliative cancer care. J Pain Symptom Manage. 2007; 33(2): 118–129.
- Teunissen SC, de Graeff A, Voest EE, et al. Are anxiety and depressed mood related to physical symptom burden? A study in hospitalized advanced cancer patients. Palliat Med. 2007; 21(4): 341–346.
- Irving G, Lloyd-Williams M. Depression in advanced cancer. Eur J Oncol Nurs. 2010; 14(5): 395–399.
- Heydarnejad M, Hasanpour D, Solati D. Factors affecting quality of life in cancer patients undergoing chemotheraphy African Health Sciences. 2011; 11(2).
- Tavoli A, Montazeri A, Roshan R, et al. Depression and quality of life in cancer patients with and without pain: the role of pain beliefs. BMC Cancer. 2008; 8: 177.
- Velenik V, Secerov-Ermenc A, But-Hadzic J, et al. Health-related quality of life assessed by the EORTC QLQ-C30 questionnaire in the general slovenian population. Radiology and Oncology. 2017; 51(3): 342–350.
- Jafari A, Goudarzian AH, Bagheri Nesami M. Depression in Women with Breast Cancer: A Systematic Review of Cross-Sectional Studies in Iran. Asian Pac J Cancer Prev. 2018; 19(1): 1–7.
- Widiyono S, Setiyarini S, Effendy C. Tingkat depresi pada pasien Kanker di RSUP Dr. Sardjito, Yogyakarta, dan RSUD Prof. Dr. Margono Soekarjo, Purwokerto: Pilot Study. Indonesian Journal of Cancer. 2017; 11(4).
- Maass SW, Roorda C, Berendsen AJ, et al. The prevalence of long-term symptoms of depression and anxiety after breast cancer treatment: A systematic review. Maturitas. 2015; 82(1): 100–108.
- Bai M, Lazenby M, Jeon S, et al. Exploring the relationship between spiritual well-being and quality of life among patients newly diagnosed with advanced cancer. Palliat Support Care. 2015; 13(4): 927–935.
- Gonzalez P, Castañeda SF, Dale J, et al. Spiritual well-being and depressive symptoms among cancer survivors. Support Care Cancer. 2014; 22(9): 2393–2400.
- Suwendar S, Fudholi A, Andayani T, et al. editors. Analisis Outcome Humanistik Pada Pasien Kanker Serviks Rawat Inap Selama Menjalani Kemoterapi Di Rumah Sakit Umum Pusat Dr. Hasan Sadikin Bandung Dengan Menggunakan Kuesioner EORTC QLQ-C30 Versi 3. SNAPP: Kesehatan (Kedokteran, Kebidanan, Keperawatan, Farmasi, Psikologi. 2015 Indonesia.
- Alshemmari S, Ezzat H, Samir Z, et al. Symptom burden in hospitalized patients with cancer in kuwait and the need for palliative care. Am J Hosp Palliat Care. 2010; 27(7): 446–449.
- Solano JP, Gomes B, Higginson IJ. A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Symptom Manage. 2006; 31(1): 58–69.
- Effendy C, Vissers K, Osse BHP, et al. Comparison of problems and unmet needs of patients with advanced cancer in a European country and an Asian country. Pain Pract. 2015; 15(5): 433–440.
- Mystakidou K, Parpa E, Panagiotou I, et al. Caregivers' anxiety and self-efficacy in palliative care. Eur J Cancer Care (Engl). 2013; 22(2): 188–195.
- Polat U, Arpacı A, Demir S, et al. Evaluation of quality of life and anxiety and depression levels in patients receiving chemotherapy for colorectal cancer: impact of patient education before treatment initiation. J Gastrointest Oncol. 2014; 5(4): 270–275.
